Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study.

breast cancer fatigue muscle performance muscle strength precision medicine quality of life rehabilitation

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 28 04 2020
accepted: 17 09 2020
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 17 11 2020
Statut: epublish

Résumé

Breast cancer fatigue (BCF) is a complex and multidimensional condition characterized by a persistent sense of physical and/or mental stiffness, resulting in a substantial impairment of health-related quality of life in breast cancer survivors. Aim of this prospective cohort study was to evaluate the feasibility and the effectiveness of a 4-week rehabilitation protocol on BCF, muscle mass, strength, physical performance, and quality of life in breast cancer (BC) survivors. We recruited adult BC women with a diagnosis of BCF, according to the International Classification of Diseases 10 criteria, referred to the Outpatient Service for Oncological Rehabilitation of a University Hospital. All participants performed a specific physical exercise rehabilitative protocol consisting of 60-min sessions repeated 2 times/week for 4 weeks. All outcomes were evaluated at the baseline (T0), at the end of the 4-week rehabilitation treatment (T1), and at 2 months follow up (T2). The primary outcome measure was the Brief Fatigue Inventory (BFI); secondary outcomes included: Fat-Free Mass and Fat Mass, assessed by Bioelectrical Impedance Analysis (BIA); Hand Grip Strength Test (HGS); Short Physical Performance Battery (SPPB); 10-meter walking test (10 MWT); 6-min walking test (6 MWT); European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). Thirty-six women (mean age: 55.17 ± 7.76 years) were enrolled in the study. Significant reduction of BCF was observed both after the 4-week rehabilitation treatment (T1) (BFI: 5.4 ± 1.6 vs. 4.2 ± 1.7;

Identifiants

pubmed: 33194622
doi: 10.3389/fonc.2020.556718
pmc: PMC7609789
doi:

Types de publication

Journal Article

Langues

eng

Pagination

556718

Informations de copyright

Copyright © 2020 Invernizzi, de Sire, Lippi, Venetis, Sajjadi, Gimigliano, Gennari, Criscitiello, Cisari and Fusco.

Références

Biores Open Access. 2019 Jul 30;8(1):121-128
pubmed: 31367476
Front Oncol. 2020 Jun 16;10:864
pubmed: 32612947
Oncologist. 2020 Apr;25(4):e610-e611
pubmed: 31943517
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):123-33
pubmed: 21051654
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
J Cachexia Sarcopenia Muscle. 2013 Sep;4(3):239-43
pubmed: 23529675
Arch Gerontol Geriatr. 2019 May - Jun;82:273-278
pubmed: 30889410
Physiother Theory Pract. 2020 Dec;36(12):1348-1353
pubmed: 30704332
BMC Cancer. 2018 Sep 29;18(1):935
pubmed: 30268112
Curr Treat Options Oncol. 2020 Feb 5;21(2):17
pubmed: 32025928
Breast Care (Basel). 2018 Apr;13(2):93-101
pubmed: 29887785
Ageing Res Rev. 2020 Mar;58:101025
pubmed: 32018055
J Natl Compr Canc Netw. 2015 Aug;13(8):1012-39
pubmed: 26285247
BMC Cancer. 2015 Feb 21;15:77
pubmed: 25885168
Breast. 2019 Apr;44:15-23
pubmed: 30580170
Support Care Cancer. 2002 Jul;10(5):389-98
pubmed: 12136222
Cancer. 1999 Mar 1;85(5):1186-96
pubmed: 10091805
Med Sci Sports Exerc. 2010 Jul;42(7):1409-26
pubmed: 20559064
Cancer Treat Rev. 2019 Mar;74:1-14
pubmed: 30658289
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8028-8035
pubmed: 32767329
Cancers (Basel). 2020 Jan 13;12(1):
pubmed: 31941005
Cancers (Basel). 2019 Nov 28;11(12):
pubmed: 31795208
J Cancer Res Clin Oncol. 2019 Oct;145(10):2583-2593
pubmed: 31401675
Eur Rev Med Pharmacol Sci. 2015 Jul;19(13):2446-51
pubmed: 26214781
Burns. 2015 Aug;41(5):990-7
pubmed: 25499405
Br J Sports Med. 2016 Mar;50(6):339-45
pubmed: 26385207
Front Endocrinol (Lausanne). 2020 Apr 15;11:204
pubmed: 32351450
Support Care Cancer. 2018 Oct;26(10):3353-3364
pubmed: 29961146
Muscle Nerve. 2011 Jan;43(1):94-102
pubmed: 21171100
Cancer Manag Res. 2020 Jan 30;12:675-686
pubmed: 32099464
Physiotherapy. 2018 Dec;104(4):400-407
pubmed: 30477677
Breast. 2017 Jun;33:166-177
pubmed: 28415013
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Curr Opin Clin Nutr Metab Care. 2015 May;18(3):221-5
pubmed: 25769061
Antioxid Redox Signal. 2020 Sep 10;33(8):542-558
pubmed: 32037856
Curr Osteoporos Rep. 2020 Aug;18(4):422-431
pubmed: 32519284
Skelet Muscle. 2012 Jul 06;2:14
pubmed: 22769563
Nutrients. 2020 Feb 22;12(2):
pubmed: 32098380
Cancer Immunol Immunother. 2017 May;66(5):667-671
pubmed: 28324125
JAMA. 2005 May 25;293(20):2479-86
pubmed: 15914748
Cochrane Database Syst Rev. 2012 Nov 14;11:CD006145
pubmed: 23152233
Aging Clin Exp Res. 2014 Aug;26(4):341-51
pubmed: 24347122
J Physiother. 2018 Jan;64(1):61
pubmed: 28645532
Biores Open Access. 2019 Jul 03;8(1):101-110
pubmed: 31275735
Nutrition. 2001 Mar;17(3):248-53
pubmed: 11312069
Cells. 2019 Jul 18;8(7):
pubmed: 31323874
Diabetes Obes Metab. 2013 Sep;15 Suppl 3:51-60
pubmed: 24003921
Brain Behav Immun. 2019 Oct;81:92-104
pubmed: 31454519
Curr Sports Med Rep. 2013 Jul-Aug;12(4):215-7
pubmed: 23851406
J Clin Med. 2020 Jan 09;9(1):
pubmed: 31936624
J Clin Oncol. 2014 Jun 10;32(17):1840-50
pubmed: 24733803
Cochrane Database Syst Rev. 2011 Jul 06;(7):CD000333
pubmed: 21735380
Neuromuscul Disord. 2017 Oct;27(10):879-882
pubmed: 28803817

Auteurs

Marco Invernizzi (M)

Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.

Alessandro de Sire (A)

Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Rehabilitation Unit, "Mons. L. Novarese" Hospital, Vercelli, Italy.

Lorenzo Lippi (L)

Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.

Konstantinos Venetis (K)

Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Ph.D. Program in Translational Medicine, University of Milan, Milan, Italy.

Elham Sajjadi (E)

Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Francesca Gimigliano (F)

Department of Mental and Physical Health and Preventive Medicine, University of Campania 'Luigi Vanvitelli', Napoli, Italy.

Alessandra Gennari (A)

Division of Medical Oncology, University Hospital "Maggiore della Carità", Novara, Italy.

Carmen Criscitiello (C)

New Drugs and Early Drug Development for Innovative Therapies Division, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Carlo Cisari (C)

Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Physical Medicine and Rehabilitation Unit, University Hospital "Maggiore della Carità", Novara, Italy.

Nicola Fusco (N)

Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Classifications MeSH